Prolidase deficiency in an infant with an incidental finding of methaemoglobinaemia

Chern Yan Tan1, Easwari Kothandaraman2, Arunabha Ghosh2

  • 1Metabolic Medicine, Royal Manchester Children's Hospital, Manchester, UK chernyantan@doctors.org.uk.

BMJ Case Reports
|November 19, 2021
PubMed

Insights

A rare genetic disorder, prolidase deficiency, was diagnosed in an infant presenting with severe gastrointestinal issues and metabolic complications. Genetic sequencing identified a pathogenic variant in the Peptidase D (PEPD) gene, confirming the diagnosis.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Prolidase deficiency is a rare autosomal recessive disorder.
  • It is caused by pathogenic variants in the Peptidase D (PEPD) gene.
  • Clinical manifestations can be severe and include gastrointestinal problems, skin lesions, and metabolic disturbances.

Observation:

  • A 4-week-old infant presented with diarrhea and vomiting, initially misdiagnosed as cow's milk allergy.
  • The infant's condition worsened, leading to metabolic acidosis and methaemoglobinaemia.
  • Rapid trio exome sequencing was performed due to the deteriorating clinical state.

Findings:

  • A homozygous pathogenic variant (c.978G>A, p.(Trp326*)) in the Peptidase D (PEPD) gene was identified.
  • This genetic finding confirmed the diagnosis of prolidase deficiency.
  • The identified variant is novel and has not been previously reported.

Implications:

  • This case highlights the importance of considering rare genetic disorders in infants with unexplained severe symptoms.
  • Early diagnosis of prolidase deficiency through genetic testing can facilitate timely management and improve patient outcomes.
  • Further research into the genotype-phenotype correlations of PEPD variants is warranted.